Ascletis Pharma Inc. (ASCLF) Financials

ASCLF Assets vs Liabilities
DateAssetsLiabilities
June 30, 2025 278.7 million 18.0 million
March 31, 2025 274.9 million 17.8 million
Dec. 31, 2024 291.1 million 21.7 million
Sept. 30, 2024 302.7 million 22.6 million

ASCLF Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
June 30, 2025 -24.1 million 535447
March 31, 2025 -11.9 million 264067
Dec. 31, 2024 -19.2 million 183168
Sept. 30, 2024 -10.0 million 95248

ASCLF Net Income

No data available :(

ASCLF Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
June 30, 2025 251.4 million - 595608
March 31, 2025 248.0 million - -
Dec. 31, 2024 266.8 million - 1.0 million
Sept. 30, 2024 278.2 million - -

ASCLF Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
June 30, 2025 134.4 million
March 31, 2025 132.5 million
Dec. 31, 2024 135.2 million
Sept. 30, 2024 140.6 million

ASCLF Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
June 30, 2025 - 20.5 million 6.0 million -
March 31, 2025 - 10.1 million 3.0 million -
Dec. 31, 2024 287013 23.3 million 8.3 million -
Sept. 30, 2024 149248 12.1 million 4.3 million -

ASCLF Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
June 30, 2025 150891 134001
March 31, 2025 74415 66085
Dec. 31, 2024 175770 75075
Sept. 30, 2024 91401 39039

ASCLF

Price: $1.30

52 week price:
1.07
2.50

Earnings Per Share: -0.05 USD

Exchange: PNK

Sector: Healthcare

Industry: Biotechnology

Market Capitalization: 1.1 billion

Links: